This L5/XT (late) off-market cross trade is interesting. That is a large cross trade. We may see surprising consequences of this cross trade.
There are only 6 holders who hold over 26m shares on the current Top 20 holder list.
First one is TG.
The 2nd one is JP Morgan Nominees, holding 98m shares. Because JPM has never lodged a substantial holder notification that means there are multiple holders in that account.
The 3rd and 5th on list belongs the same person; Graham Kluck.
The 4th is Citicorp, may belong to multiple holders.
Maybe a new holder accumulated some shares since Dec.2 (the date of current Top Holder on LTR web site) in 2 differetn accounts and now has transferred them to the main account.
Maybe Janus Henderson Fund or Australian Super have organised to acquire some off-market shares. We may see one or both of them on the Top 20 list soon. (We already know JH fund mentioned that they owned LTR shares. And I can't imagine if Aust.Super is not buying LTR shares atm).
We will wait and see.
- Forums
- ASX - By Stock
- LTR
- ASX Today
ASX Today, page-1609
-
- There are more pages in this discussion • 40,009 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 54268 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online